Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novel CRH-R1 antagonist shows potential for the treatment of alcohol abuse

Dec. 19, 2006

Champix launched in U.K.

Dec. 4, 2006

Lundbeck and Biotie sign agreement for nalmefene

Nov. 29, 2006

New series of synthetic CLIP-derived peptides disclosed in recent patent

Nov. 27, 2006

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Nov. 2, 2006

Probuphine begins phase III trial for treatment of opioid dependence

Oct. 30, 2006

Sazetidine-A: a new desensitizing nicotinic ligand

Oct. 26, 2006

Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity

Oct. 23, 2006

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Oct. 11, 2006

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Oct. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.